Index - P/E 23.94 EPS (ttm) 13.10 Insider Own 19.02% Shs Outstand 29.77M Perf Week 4.41%
Market Cap 9.02B Forward P/E 23.80 EPS next Y 13.18 Insider Trans -0.10% Shs Float 23.27M Perf Month 11.13%
Income 416.39M PEG 4.58 EPS next Q 2.99 Inst Own 92.09% Short Float 11.48% Perf Quarter -11.50%
Sales 2.16B P/S 4.18 EPS this Y 1.13% Inst Trans -0.82% Short Ratio 5.14 Perf Half Y -12.43%
Book/sh 19.94 P/B 15.73 EPS next Y 3.20% ROA 22.55% Short Interest 2.67M Perf Year -19.06%
Cash/sh 15.36 P/C 20.43 EPS next 5Y 5.23% ROE 65.82% 52W Range 250.05 - 459.77 Perf YTD -5.57%
Dividend Est. - P/FCF 16.67 EPS past 5Y 36.50% ROI 57.81% 52W High -31.76% Beta 1.53
Dividend TTM - Quick Ratio 0.73 Sales past 5Y 19.95% Gross Margin 30.16% 52W Low 25.47% ATR (14) 13.45
Dividend Ex-Date - Current Ratio 0.73 EPS Y/Y TTM 32.81% Oper. Margin 21.16% RSI (14) 55.83 Volatility 3.38% 4.31%
Employees 5900 Debt/Eq 0.25 Sales Y/Y TTM 9.87% Profit Margin 19.31% Recom 2.67 Target Price 301.00
Option/Short Yes / Yes LT Debt/Eq 0.21 EPS Q/Q 14.63% Payout 0.00% Rel Volume 0.62 Prev Close 296.03
Sales Surprise 6.12% EPS Surprise 19.95% Sales Q/Q 9.30% Earnings Apr 21 AMC Avg Volume 519.29K Price 313.74
SMA20 4.82% SMA50 1.70% SMA200 -7.38% Trades
Volume 321,078 Change 5.98%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-22-25 Downgrade William Blair
Outperform → Mkt Perform
Apr-14-25 Downgrade TD Cowen
Buy → Hold
$328
Mar-24-25 Initiated Leerink Partners
Market Perform
$330
Oct-23-24 Downgrade Robert W. Baird
Outperform → Neutral
$413 → $349
Oct-14-24 Initiated Redburn Atlantic
Buy
Sep-27-24 Downgrade UBS
Buy → Neutral
$420 → $350
Sep-25-24 Downgrade Jefferies
Buy → Hold
$415 → $345
Aug-01-24 Initiated Truist
Hold
$415
May-29-24 Initiated TD Cowen
Buy
$452
May-28-24 Initiated Mizuho
Buy
$435
Apr-23-24 Upgrade Jefferies
Hold → Buy
$340 → $450
Mar-18-24 Initiated Deutsche Bank
Hold
$395
Feb-15-24 Upgrade UBS
Neutral → Buy
$282 → $452
Oct-24-23 Upgrade Robert W. Baird
Neutral → Outperform
$270 → $289
May-08-23 Upgrade Guggenheim
Neutral → Buy
$252
Oct-27-22 Upgrade UBS
Sell → Neutral
$142 → $238
Sep-07-22 Initiated UBS
Sell
$142
May-24-22 Initiated Guggenheim
Neutral
Aug-05-21 Resumed Credit Suisse
Outperform
$205
Oct-02-20 Upgrade Truist
Hold → Buy
$124 → $135
Show Previous Ratings
Apr-30-25 04:33AM
Apr-28-25 08:46PM
11:59AM
11:40AM
03:08AM
12:09PM
Loading…
Apr-25-25 12:09PM
Apr-24-25 10:08AM
07:35AM
Apr-23-25 03:04AM
12:15AM
(Thomson Reuters StreetEvents)
Apr-22-25 04:03PM
(Investor's Business Daily)
03:42PM
03:21PM
02:32PM
Apr-21-25 05:25PM
04:24PM
Loading…
04:24PM
04:21PM
(Associated Press Finance)
04:15PM
Apr-20-25 08:00AM
Apr-18-25 08:31AM
Apr-15-25 10:00AM
08:55AM
Apr-14-25 10:00AM
Apr-11-25 11:40AM
Apr-10-25 09:13AM
06:15AM
05:08AM
Apr-07-25 06:15PM
Apr-05-25 06:58AM
Apr-04-25 09:14AM
08:14AM
Loading…
08:14AM
Apr-02-25 08:00AM
06:00AM
Mar-28-25 03:59PM
Mar-27-25 07:05PM
06:37PM
Mar-24-25 06:15PM
12:33PM
11:40AM
Mar-21-25 05:03AM
Mar-18-25 04:05PM
Mar-03-25 04:04AM
Feb-17-25 08:55AM
Feb-14-25 08:00AM
Feb-12-25 09:12AM
02:08AM
12:06AM
(Thomson Reuters StreetEvents)
Feb-11-25 11:54AM
Feb-10-25 04:39PM
(Associated Press Finance)
04:33PM
04:15PM
Feb-09-25 08:03AM
Feb-07-25 08:14AM
Jan-20-25 08:55AM
Jan-03-25 08:27AM
Jan-02-25 04:05PM
Nov-21-24 06:52PM
Nov-15-24 06:47PM
(Morningstar Research) -7.23%
Nov-06-24 06:36PM
(Morningstar Research) +9.15%
Nov-04-24 10:12AM
Nov-01-24 07:33PM
Oct-29-24 09:00PM
Oct-23-24 03:56AM
(Thomson Reuters StreetEvents)
Oct-22-24 05:42PM
(Morningstar Research) -7.47%
04:04PM
(Investor's Business Daily)
10:09AM
Oct-21-24 04:25PM
(Associated Press Finance)
04:15PM
Oct-16-24 11:23AM
10:44AM
Oct-10-24 01:56PM
07:42AM
Oct-08-24 09:00PM
Sep-30-24 09:00PM
Sep-24-24 05:26PM
04:05PM
Aug-30-24 09:00PM
Aug-29-24 12:40PM
Aug-26-24 04:02PM
Aug-19-24 09:00PM
Aug-16-24 06:45AM
Aug-15-24 02:48PM
Aug-12-24 10:11AM
Aug-05-24 04:08PM
Aug-02-24 07:46PM
Jul-25-24 10:04AM
Jul-24-24 01:01AM
12:55AM
(Thomson Reuters StreetEvents)
Jul-23-24 06:24PM
(Morningstar Research) -18.27%
Jul-22-24 04:21PM
(Associated Press Finance)
04:15PM
Jul-19-24 11:50AM
Jul-18-24 09:15AM
Jul-12-24 06:15PM
Jul-11-24 12:00PM
Jun-28-24 09:15AM
Jun-27-24 06:37PM
Jun-26-24 06:15PM
04:05PM
Jun-18-24 06:13AM
(Pharmaceutical Technology)
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DAVENPORT FRED B JR Director Apr 24 '25 Option Exercise 57.17 4,710 269,271 4,710 Apr 28 04:39 PM DAVENPORT FRED B JR Director Apr 24 '25 Sale 301.82 1,712 516,716 2,998 Apr 28 04:39 PM DAVENPORT FRED B JR Director Apr 24 '25 Proposed Sale 301.82 1,712 516,716 Apr 24 02:13 PM Troendle August J. CEO Mar 07 '25 Option Exercise 68.62 356,446 24,458,835 1,011,102 Mar 10 05:47 PM EWALD STEPHEN P General Counsel & Corp. Secy. Feb 27 '25 Buy 326.11 2 652 13,343 Feb 28 04:39 PM Carley Brian T Director Feb 24 '25 Option Exercise 42.62 8,127 346,373 30,035 Feb 26 04:18 PM Carley Brian T Director Feb 24 '25 Sale 345.59 4,003 1,383,397 26,032 Feb 26 04:18 PM Carley Brian T Director Feb 24 '25 Proposed Sale 345.59 4,003 1,383,385 Feb 24 12:52 PM GEIGER JESSE J President Dec 06 '24 Option Exercise 32.05 15,000 480,750 36,503 Dec 10 04:24 PM BURWIG SUSAN E Exec. VP, Operations Nov 19 '24 Option Exercise 32.05 7,500 240,375 65,000 Nov 21 04:40 PM Kraft Robert O. Director Aug 22 '24 Option Exercise 42.62 4,353 185,525 4,873 Aug 26 04:37 PM Kraft Robert O. Director Aug 23 '24 Option Exercise 42.62 3,774 160,848 4,294 Aug 26 04:37 PM Kraft Robert O. Director Aug 22 '24 Sale 390.73 4,353 1,700,848 520 Aug 26 04:37 PM Kraft Robert O. Director Aug 23 '24 Sale 390.73 3,774 1,474,615 520 Aug 26 04:37 PM Kraft Robert O. Director Aug 22 '24 Proposed Sale 390.73 4,353 1,700,858 Aug 22 04:20 PM Keating Ashley M. Former Director Aug 16 '24 Proposed Sale 387.00 769 297,603 Aug 16 04:58 PM Keating Ashley M. Former Director Aug 15 '24 Proposed Sale 388.00 958 371,704 Aug 15 06:27 PM Keating Ashley M. Former Director Aug 09 '24 Proposed Sale 388.29 1,403 544,767 Aug 09 03:50 PM BURWIG SUSAN E Exec. VP, Operations Aug 05 '24 Option Exercise 90.65 50,000 4,532,500 57,500 Aug 07 04:22 PM Keating Ashley M. Former Director Aug 06 '24 Proposed Sale 382.50 2,000 765,000 Aug 06 05:27 PM Keating Ashley M. Former Director Jul 30 '24 Proposed Sale 389.69 1,300 506,600 Jul 30 01:23 PM BURWIG SUSAN E Exec. VP, Operations Jun 05 '24 Sale 401.20 7,681 3,081,617 7,500 Jun 07 04:17 PM Troendle August J. CEO May 28 '24 Sale 395.49 5,695 2,252,316 654,656 May 29 04:24 PM Troendle August J. CEO May 24 '24 Sale 395.22 3,987 1,575,742 660,351 May 29 04:24 PM Troendle August J. CEO May 22 '24 Sale 400.00 55 22,000 664,338 May 24 04:10 PM Troendle August J. CEO May 20 '24 Sale 400.19 4,020 1,608,764 664,393 May 22 04:20 PM Troendle August J. CEO May 15 '24 Sale 405.13 32,282 13,078,407 675,473 May 17 04:12 PM Troendle August J. CEO May 16 '24 Sale 403.09 7,060 2,845,815 668,413 May 17 04:12 PM
